Exact Sciences (EXAS) Misses Q1 EPS by 12c; maintains guidance
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Research and development: 7.63M
Today's EPS Names:
MAYS, CRMT, REPL, More
Financial Fact:
Research and development: 7.63M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q1 EPS of ($0.60), $0.12 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $638 million versus the consensus estimate of $627.35 million.
GUIDANCE:
Exact Sciences sees FY2024 revenue of $2.81-2.85 billion, versus the consensus of $2.833 billion.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Carnival shares drop despite earnings beat on weak guidance
- Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
